dengu
viru
caus
dengu
fever
debilit
diseas
increas
incid
mani
tropic
subtrop
territori
far
effect
antivir
licens
treat
viru
describ
synthesi
antivir
activ
evalu
two
compound
base
quinolin
scaffold
shown
potenti
develop
molecul
variou
biolog
activ
two
test
compound
show
dosedepend
inhibit
dengu
viru
serotyp
low
sub
micromolar
rang
compound
also
abl
impair
accumul
viral
envelop
glycoprotein
infect
cell
show
sign
direct
virucid
activ
act
possibl
mechan
involv
earli
stage
infect
result
congruent
previous
report
data
show
potenti
quinolin
deriv
promis
scaffold
develop
new
antivir
import
viru
molecul
antivir
might
use
case
sever
dengu
high
viremia
shown
correl
sever
quinolin
heterocycl
molecul
compos
fuse
benzen
pyridin
ring
quinolin
deriv
shown
wide
rang
biolog
activ
includ
antiprolif
antivir
antibacteri
antifung
antiinflammatori
antiparasit
member
quinolin
famili
chloroquin
hydroxychloroquin
shown
antivir
activ
sever
virus
coronavirus
human
immunodefici
viru
respiratori
syncyti
viru
concern
flaviviru
quinolin
deriv
prove
activ
hepat
c
viru
west
nile
viru
japanes
enceph
viru
zika
viru
dengu
viru
sinc
quinolin
scaffold
shown
high
potenti
develop
new
molecul
antivir
activ
decid
synthes
test
sever
quinolin
deriv
relat
compound
describ
synthesi
screen
character
antivir
activ
two
novel
quinolin
deriv
dengu
viru
serotyp
vitro
quinolin
compound
shown
potenti
new
scaffold
develop
drug
pharmacolog
activ
variou
human
pathogen
includ
virus
order
investig
possibl
antivir
potenti
sever
new
quinolin
deriv
synthes
number
deriv
compound
test
abil
impair
infect
mediumthroughput
assay
base
cellular
atp
detect
synthet
substitut
quinolin
access
quinolin
quinolin
noxid
precursor
noxid
typic
prepar
noxid
quinolin
sever
method
recent
develop
prepar
substitut
quinolin
unsubstitut
precursor
found
modif
recent
develop
n
n
n
n
tetramethylethylenediamin
tmeda
catalyz
synthesi
quinolin
provid
optim
yield
puriti
quinolin
noxid
although
coppercatalyz
reaction
grignard
reagent
gave
similar
result
scheme
use
tmedacatalyz
reaction
quinolin
isol
yield
respect
subsequ
chlorin
nchlorosuccinimid
nc
acid
condit
afford
desir
quinolin
yield
respect
scheme
supplementari
materi
final
puriti
compound
verifi
higher
molecul
x
peer
review
dengu
fever
viral
reemerg
diseas
affect
human
popul
tropic
subtrop
region
estim
indic
countri
affect
million
peopl
becom
infect
year
approxim
death
diseas
caus
dengu
viru
result
grow
uncontrol
infect
transmit
mosquito
aed
genu
diseas
seriou
public
health
concern
caus
rang
clinic
manifest
mild
febril
ill
primari
infect
deadli
sever
dengu
secondari
infect
epidemiolog
situat
complex
mani
affect
countri
due
intens
transmiss
rate
coexist
four
serotyp
high
vector
invas
increas
global
human
mobil
dengu
viru
belong
flaviviru
genu
flavivirida
famili
circul
four
major
serotyp
induc
longterm
crossprotect
secondari
infect
develop
effect
vaccin
dengu
viru
technic
challeng
must
induc
balanc
immun
protect
four
serotyp
addit
specif
antivir
therapi
approv
patient
dengu
diseas
gener
symptomat
treatment
sinc
approv
antivir
viru
identif
new
antivir
import
endeavor
although
viremia
shortliv
dengu
patient
use
effect
effect
antivir
might
use
case
sever
dengu
high
viremia
shown
correl
sever
quinolin
heterocycl
molecul
compos
fuse
benzen
pyridin
ring
quinolin
deriv
shown
wide
rang
biolog
activ
includ
antiprolif
antivir
antibacteri
antifung
antiinflammatori
antiparasit
member
quinolin
famili
chloroquin
hydroxychloroquin
shown
antivir
activ
sever
virus
coronavirus
human
immunodefici
viru
respiratori
syncyti
viru
concern
flaviviru
quinolin
deriv
prove
activ
hepat
c
viru
west
nile
viru
japanes
enceph
viru
zika
viru
dengu
viru
sinc
quinolin
scaffold
shown
high
potenti
develop
new
molecul
antivir
activ
decid
synthes
test
sever
quinolin
deriv
relat
compound
describ
synthesi
screen
character
antivir
activ
two
novel
quinolin
deriv
dengu
viru
serotyp
vitro
quinolin
compound
shown
potenti
new
scaffold
develop
drug
pharmacolog
activ
variou
human
pathogen
includ
virus
order
investig
possibl
antivir
potenti
sever
new
quinolin
deriv
synthes
number
deriv
compound
test
abil
impair
infect
mediumthroughput
assay
base
cellular
atp
detect
synthet
substitut
quinolin
access
quinolin
quinolin
noxid
precursor
noxid
typic
prepar
noxid
quinolin
sever
method
recent
develop
prepar
substitut
quinolin
unsubstitut
precursor
found
modif
recent
develop
n
n
tmeda
catalyz
synthesi
quinolin
provid
optim
yield
puriti
quinolin
noxid
although
coppercatalyz
reaction
grignard
reagent
gave
similar
result
scheme
use
tmedacatalyz
reaction
quinolin
isol
yield
respect
subsequ
chlorin
nchlorosuccinimid
nc
acid
condit
afford
desir
quinolin
yield
respect
scheme
supplementari
materi
final
puriti
compound
verifi
higher
total
compound
deriv
quinolin
scaffold
relat
compound
tabl
supplementari
materi
test
prescreen
stage
antivir
activ
cytotox
assay
singl
concentr
point
data
shown
test
compound
prescreen
step
either
show
inhibit
display
evid
cytotox
data
shown
base
result
prescreen
stage
three
compound
select
confirmatori
test
antivir
activ
cytotox
explor
use
doserespons
approach
confirmatori
viral
yield
reduct
assay
compound
show
consist
inhibitori
activ
vitro
figur
compound
show
inhibitori
activ
half
maxim
inhibitori
concentr
half
maxim
cytotox
concentr
scheme
synthesi
quinolin
deriv
compound
total
compound
deriv
quinolin
scaffold
relat
compound
tabl
supplementari
materi
test
prescreen
stage
antivir
activ
cytotox
assay
singl
concentr
point
data
shown
test
compound
prescreen
step
either
show
inhibit
display
evid
cytotox
data
shown
base
result
prescreen
stage
three
compound
select
confirmatori
test
antivir
activ
cytotox
explor
use
doserespons
approach
confirmatori
viral
yield
reduct
assay
compound
show
consist
inhibitori
activ
vitro
figur
compound
show
inhibitori
activ
half
maxim
inhibitori
concentr
ic
half
maxim
cytotox
concentr
cc
estim
select
index
si
figur
compound
also
activ
show
higher
si
ic
cc
figur
explor
mechan
action
compound
measur
capac
impair
product
viral
envelop
glycoprotein
key
protein
flaviviru
life
cycl
e
glycoprotein
assess
western
blot
purpos
cell
treat
sever
concentr
compound
fortyeight
hour
post
infect
infect
cell
treat
compound
show
signific
dosedepend
reduct
amount
envelop
protein
detect
western
blot
figur
reduct
statist
signific
compound
concentr
p
p
respect
compound
p
explor
mechan
action
compound
measur
capac
impair
product
viral
envelop
glycoprotein
key
protein
flaviviru
life
cycl
e
glycoprotein
assess
western
blot
purpos
cell
treat
sever
concentr
compound
fortyeight
hour
post
infect
infect
cell
treat
compound
show
signific
dosedepend
reduct
amount
envelop
protein
detect
western
blot
figur
reduct
statist
signific
compound
concentr
p
p
respect
compound
p
figur
effect
compound
signific
ad
preinfect
period
adsorpt
phase
suggest
action
due
virucid
activ
significantli
differ
viru
control
compound
show
small
effect
viru
infect
ad
adsorpt
phase
suggest
possibl
virucid
activ
impair
attachmententri
process
compound
also
significantli
reduc
viral
yield
present
h
time
point
figur
similarli
effect
notic
ad
preinfect
viral
adsorpt
result
suggest
compound
act
least
affect
earli
event
viru
life
cycl
sinc
certain
activ
antivir
molecul
may
act
upon
direct
contact
virion
want
evalu
compound
virucid
activ
incub
virion
one
hour
compound
correspond
vehicl
dmso
prior
adsorpt
monolay
show
signific
reduct
viral
titer
figur
result
suggest
antivir
effect
molecul
due
direct
virucid
activ
figur
effect
compound
signific
ad
preinfect
period
adsorpt
phase
suggest
action
due
virucid
activ
significantli
differ
viru
control
compound
show
small
effect
viru
infect
ad
adsorpt
phase
suggest
possibl
virucid
activ
impair
attachmententri
process
compound
also
significantli
reduc
viral
yield
present
h
time
point
figur
similarli
effect
notic
ad
preinfect
viral
adsorpt
result
suggest
compound
act
least
affect
earli
event
viru
life
cycl
sinc
certain
activ
antivir
molecul
may
act
upon
direct
contact
virion
want
evalu
compound
virucid
activ
incub
virion
one
hour
compound
correspond
vehicl
dmso
prior
adsorpt
monolay
show
signific
reduct
viral
titer
figur
result
suggest
antivir
effect
molecul
due
direct
virucid
activ
quinolin
moieti
commonli
found
natur
product
show
wide
varieti
biolog
activ
base
fact
mani
synthet
deriv
synthes
examin
pharmacolog
activ
properti
current
sever
approv
drug
contain
quinolin
structur
core
bedaquilin
semisynthet
irinotecan
drug
resist
tuberculosi
colorect
cancer
respect
shown
two
novel
deriv
quinolin
scaffold
antivir
activ
low
micromolar
rang
result
encourag
character
improv
biolog
activ
profil
new
synthet
variant
compound
also
show
signific
dosedepend
effect
product
viral
envelop
glycoprotein
congruent
antivir
activ
shown
viru
yield
reduct
assay
effect
commonli
observ
molecul
antivir
activ
dengu
viru
data
suggest
antivir
activ
due
direct
virucid
activ
compound
seem
act
earli
stage
viral
life
cycl
experiment
data
requir
precis
describ
target
compound
result
consist
publish
data
show
potenti
scaffold
develop
new
antivir
sever
report
describ
deriv
scaffold
potent
inhibitor
sever
flavivirus
includ
west
nile
viru
amodiaquin
deriv
recent
describ
activ
addit
quinolin
deriv
compound
found
potent
inhibitor
polymeras
hepat
c
viru
flaviviru
affect
million
peopl
worldwid
certain
quinolin
deriv
shown
divers
biolog
activ
exampl
chloroquin
antimalari
activ
also
shown
inhibit
flaviviru
replic
well
virus
influenza
hiv
coronaviru
activ
molecul
studi
structur
relat
chlorquinaldol
uniqu
chemic
structur
identifi
cid
accord
pubchem
databas
http
pubchemncbi
quinolin
moieti
commonli
found
natur
product
show
wide
varieti
biolog
activ
base
fact
mani
synthet
deriv
synthes
examin
pharmacolog
activ
properti
current
sever
approv
drug
contain
quinolin
structur
core
bedaquilin
semisynthet
irinotecan
drug
resist
tuberculosi
colorect
cancer
respect
shown
two
novel
deriv
quinolin
scaffold
antivir
activ
low
micromolar
rang
result
encourag
character
improv
biolog
activ
profil
new
synthet
variant
compound
also
show
signific
dosedepend
effect
product
viral
envelop
glycoprotein
congruent
antivir
activ
shown
viru
yield
reduct
assay
effect
commonli
observ
molecul
antivir
activ
dengu
viru
data
suggest
antivir
activ
due
direct
virucid
activ
compound
seem
act
earli
stage
viral
life
cycl
experiment
data
requir
precis
describ
target
compound
result
consist
publish
data
show
potenti
scaffold
develop
new
antivir
sever
report
describ
deriv
scaffold
potent
inhibitor
sever
flavivirus
includ
west
nile
viru
amodiaquin
deriv
recent
describ
activ
addit
quinolin
deriv
compound
found
potent
inhibitor
polymeras
hepat
c
viru
flaviviru
affect
million
peopl
worldwid
certain
quinolin
deriv
shown
divers
biolog
activ
exampl
chloroquin
antimalari
activ
also
shown
inhibit
flaviviru
replic
well
virus
influenza
hiv
coronaviru
activ
molecul
studi
structur
relat
chlorquinaldol
uniqu
chemic
structur
identifi
cid
accord
pubchem
databas
http
pubchemncbinlmnih
govcompoundchlorquinaldol
compound
found
activ
marburg
viru
venezuelan
equin
enceph
viru
footandmouth
diseas
viru
howev
assay
chlorquinaldol
activ
data
shown
suggest
modif
shown
critic
observ
antivir
activ
addit
sever
compound
test
initi
screen
differ
also
inact
emphas
role
alkyl
group
shown
compound
data
shown
similarli
relat
deriv
includ
report
activ
rou
sarcoma
viru
herp
simplex
viru
due
inhibit
rnadepend
dna
polymeras
investig
shown
deriv
strong
vitro
inhibitor
west
nile
viru
proteas
well
proteas
sub
micromolar
rang
shown
two
novel
quinolin
deriv
activ
dosedepend
manner
result
import
start
point
elucid
precis
mechan
antivir
activ
gain
requir
knowledg
develop
new
potent
safe
drug
reduc
infect
caus
relev
pathogen
vero
cell
dengu
viru
serotyp
kind
gift
dr
sandra
instituto
conmemorativo
gorga
de
estudio
de
la
salud
vero
cell
grown
minim
essenti
medium
mem
supplement
fetal
bovin
serum
fb
fb
reduc
mainten
medium
use
viru
assay
evalu
compound
synthes
describ
antivir
assay
lyophil
synthet
compound
resuspend
dimethyl
sulfoxid
dmso
sigmaaldrich
st
loui
mo
usa
compound
synthesi
purif
anhydr
tetrahydrofuran
collect
argon
solvent
purif
system
lc
technolog
solut
salisburi
usa
pass
two
column
pack
molecular
siev
noxid
prepar
accord
literatur
procedur
n
n
n
n
tetramethylethylenediamin
tmeda
freshli
distil
calcium
hydrid
chemic
use
commerci
avail
reaction
conduct
continu
magnet
stir
atmospher
argon
ovendri
glasswar
reaction
monitor
h
nmr
tlc
silicagelco
glass
plate
merck
kieselgel
merck
kgaa
darmstadt
germani
deem
complet
plate
visual
ultraviolet
light
nm
stain
ceric
ammonium
molybd
cam
potassium
permangan
column
chromatographi
perform
use
combiflash
teledyneisco
lincoln
ne
usa
autom
flash
chromatographi
system
solut
noxid
mg
mmol
n
n
n
n
tetramethylethylenediamin
ml
mmol
mixtur
thf
ml
cyclohexan
ml
pressur
tube
ad
isopropylmagnesium
chlorid
solut
thf
ml
mmol
reaction
heat
c
h
cool
quench
nh
cl
ml
extract
etoac
ml
organ
phase
combin
dri
anhydr
na
concentr
reduc
pressur
crude
product
purifi
prepar
tlc
etoachexan
vv
give
mg
lightgreen
solidmp
c
cytopath
effect
caus
quantifi
mediumto
highthroughput
assay
measur
cellular
atp
level
commerci
avail
kit
celltiterglo
promega
corpor
madison
wi
usa
use
recommend
manufactur
assay
condit
optim
best
signaltonois
ratio
lab
condit
optim
paramet
includ
vero
cell
per
well
plate
multipl
infect
moi
hit
defin
compound
produc
signal
threshold
defin
mean
untreat
infect
cell
plu
three
standard
deviat
vero
cell
cell
seed
plate
complet
medium
incub
h
c
co
atmospher
monolay
wash
phosphatebuff
salin
pb
infect
moi
c
occasion
agit
h
viru
aspir
cell
wash
pb
replenish
mainten
medium
contain
compound
sever
concentr
vehicl
fortyeight
hour
later
supernat
recov
viru
yield
quantifi
plaqu
assay
plaqu
assay
cell
seed
per
well
plate
complet
medium
incub
h
monolay
wash
pb
infect
sever
dilut
collect
supernat
use
per
well
h
c
occasion
agit
infect
cell
cover
overlay
contain
mainten
medium
plu
seaplaqu
agaros
lonza
group
ltd
basel
switzerland
incub
day
formaldehyd
pb
ad
h
room
temperatur
overlay
plug
discard
cell
stain
crystal
violet
ethanol
min
wash
run
water
plate
dri
plaqu
count
reduct
viru
yield
express
reduct
viru
titer
compoundtr
cell
compar
nontreat
virusonli
control
cytotox
compound
assess
atp
detect
use
commerci
avail
kit
per
manufactur
instruct
celltiterglo
promega
madison
wi
usa
briefli
vero
cell
seed
per
well
plate
use
complet
medium
h
medium
replac
sever
concentr
compound
mainten
medium
incub
h
freshli
reconstitut
atp
detect
reagent
ad
well
plate
care
agit
min
cell
lysat
transfer
opaqu
white
plate
thermo
fisher
scientif
waltham
usa
cat
luminesc
signal
detect
min
use
multidetect
micropl
reader
synergi
ht
biotek
winooski
vt
usa
cytotox
express
reduct
luminesc
signal
compoundtr
cell
compar
nontreat
cell
cell
lysat
prepar
infect
compoundtr
cell
h
post
infect
twentyf
microgram
total
protein
load
sdspage
gel
nonreduc
condit
electrophoresi
protein
transfer
pvdf
membran
amersham
uk
block
wv
bsa
trisbuff
salin
tb
contain
vv
block
membran
incub
overnight
c
antienvelop
primari
antibodi
absolut
antibodi
redcar
uk
horseradish
peroxidas
hrp
conjug
rabbit
antimous
signal
develop
use
chemiluminesc
blot
strip
reprob
santa
cruz
biotechnolog
dalla
tx
usa
load
control
signal
correspond
envelop
protein
normal
load
control
use
imag
studio
lite
licor
lincoln
ne
usa
recommend
manufactur
vero
cell
seed
infect
describ
confirmatori
viru
yield
reduct
assay
except
compound
ad
sever
time
point
preincub
compound
ad
h
infect
remov
viru
adsorpt
incub
infect
timepoint
compound
ad
incub
cell
h
exactli
viral
adsorpt
period
remov
cell
wash
postinfect
timepoint
compound
ad
h
mainten
medium
kept
h
post
infect
supernat
collect
viru
titer
determin
plaqu
assay
compound
correspond
vehicl
dmso
equival
concentr
incub
pfu
h
c
mainten
medium
sampl
dilut
mainten
medium
test
plaqu
assay
determin
viral
surviv
treatment
data
present
mean
standard
error
mean
three
independ
experi
mean
group
compar
viru
control
use
onesampl
ttest
implement
graphpad
prism
statist
signific
differ
consid
p
half
maxim
inhibitori
concentr
ic
half
maxim
cytotox
concentr
cc
calcul
fit
nonlin
regress
model
data
four
paramet
logist
variabl
slope
model
implement
graphpad
prism
select
index
si
calcul
ratio
cc
ic
describ
two
novel
quinolin
deriv
activ
dengu
viru
serotyp
compound
virucid
appear
act
earli
stage
viru
life
cycl
reduc
intracellular
product
envelop
glycoprotein
yield
infect
virion
treat
infect
cell
result
import
start
point
develop
new
safer
antivir
import
viru
supplementari
materi
follow
avail
onlin
figur
spectral
data
compound
shown
studi
tabl
structur
compound
test
virucid
activ
studi
